It has bewildered the medical community by publishing, on 22 may, a study designed to prove the ineffectiveness and toxicity of hydroxychloroquine against the Covid-19. The scientific journal The Lancet is now in doubt. To the extent that it has, in a notice dated June 2, announced that a “independent audit on the origin and validity of the data “ had been ordered. The results could lead to the withdrawal of the study.
→ EXPLANATION. Hydroxychloroquine : WHO takes the tests
On may 28, about 120 scientists of different nationalities had denounced the methodology of the observational study, built on the analysis of the medical records of 96 000 patients of the 671 hospitals around the world. Among the items challenged : false numbers, including the number of deaths in Australia, the dose of administration or the impossibility of access to the raw data collected.
A study if the expected a-t-it could be the subject of a failure of vigilance ? “The absolute urgency of the situation and the spirit of things around the chloroquine are that everyone loses a bit of its fundamentals. It is possible that in wanting to go fast, it lowers the level requirement “, writes professor Jean-François Bergmann, himself a co-author of two studies published in The Lancet. While it lasted only a few weeks to the study on the hydroxychloroquine, the process of proofreading and peer review can take up to six months in normal times.
The Lancet would be ” more in the provocation “
Six months, during which 3, 4 or 5 reviewers, scientists, specialists in the topic, without link of interest with the author, volunteer, and anonymous, judge the rigour of the study and submit their opinions to the editor-in-chief : “It is almost glory as of to be reviewer for The Lancet “smiles Jean-François Bergmann. A race to the reputation, justly, and the competitiveness that tends to undermine the research.
→ TO READ. Chloroquine : banned, but still prescribed
“The journals are listed according to their “impact factor”, that is, the number of times their articles are cited in other studies. The more the impact factor is important, more the magazine will weigh with the industry, including “ analysis Jean-François Bergmann.
Thus, if the journal The New England Journal of Medicine is readily qualified to rigorous, The Lancet would be “more in the provocation “recounts professor of therapeutic : “There has to see the cover page : on the of The Lancet it is not written “journal of medicine” but “newspaper”. It feels a search of the scoop and the speed. “
Up to the outburst ? In 1998, The Lancet published an infringing article linking autism to vaccination. Before you do remove it… twelve years later.